NCT04240496View on ClinicalTrials.gov

Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 17, 2019

Primary Completion Date

December 14, 2019

Study Completion Date

December 14, 2019

Conditions
CYP1A2 PolymorphismCYP2C19 PolymorphismClozapineSchizophrenia
Interventions
OTHER

Determination of plasma concentration of clozapine/ Genotyping

Determination of trough plasma concentration of clozapine (C0) Genotyping of CYP1A2 \& CYP2C19

Trial Locations (1)

5000

Faculty of Medecine of Monastir, Monastir

All Listed Sponsors
lead

University of Monastir

OTHER

NCT04240496 - Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics | Biotech Hunter | Biotech Hunter